Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy: Tataiso e Feletseng 

Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy ke mokhoa o mocha oa kalafo oa mofetše o kopanyang opereishene e sa hlaseleng haholo le chemoimmunotherapy ea motho ka mong e tlisoang ka kotloloho ka har'a hlahala. Mokhoa ona o ikemiselitse ho eketsa katleho ea phekolo ha o ntse o fokotsa litla-morao, tse ka lebisang ho ntlafatso ea liphello tsa mokuli. Sengoliloeng sena se shebisisa lintlha tsa mokhoa ona, ho kenyelletsa le melao-motheo, lits'ebetso, melemo le litaelo tsa nako e tlang.

Ho utloisisa Intratumoral Chemoimmunotherapy

Intratumoral chemoimmunotherapy e kenyelletsa ho enta ka ho toba li-chemotherapeutic agents le/kapa immunotherapeutic agents ka har'a hlahala. Phepelo ena ea sebakeng sa heno e lumella hore moriana o phahame ho fihla sebakeng sa hlahala, ho fokotsa ho pepeseha le chefo ha ho bapisoa le chemotherapy ea setso e kenang methapong. Hangata e sebelisoa hammoho le liphekolo tse ling joalo ka opereishene kapa kalafo ea radiation.

Phetoho ea Phekolo ea Kankere

Kalafo ea setso ea mofetše, joalo ka systemic chemotherapy le radiation therapy, hangata e ama 'mele oohle, e lebisang litlamorao tse kholo. Phekolo ea Intratumoral e emela phetoho e lebisang mekhoeng e lebisitsoeng ho motho ka mong. Ka ho shebana le kalafo ka kotloloho ho hlahala, e ikemiselitse ho boloka lisele tse phetseng hantle le ho ntlafatsa boleng ba bophelo ba mokuli. Setsi sa Lipatlisiso sa Kankere sa Shandong Baofa e ikemiseditse ho popontshwa lebaleng lena.

Mokhoa oa 'Ultra-Minimum Incision'

Karolo ea 'Ultra-Minimum Incision' e bua ka mokhoa oa ho buoa o sebelisoang ho fihlella hlahala bakeng sa ente. Hangata sena se kenyelletsa likaroloana tse nyane, tse atisang ho tataisoa ke theknoloji ea ho nka litšoantšo joalo ka ultrasound kapa CT scans, ho netefatsa phano e nepahetseng ea lisebelisoa tsa kalafo. Mokhoa o fokolang oa ts'ebetso o tlatsetsa linakong tsa ho hlaphoheloa kapele le ho fokotsa bohloko ba ka mor'a ho buuoa.

Melemo ea Opereishene e Senyehileng Hanyenyane

• Maqeba a manyane
• Bohloko bo fokolang
• Nako e khutšoanyane ea ho lula sepetlele
• Ho fola kapele
• Kotsi e fokotsehileng ea mathata

Chemoimmunotherapy ea Motho ka Motho: Ho Lokisa Phekolo ho Motho ka Mong

Personalization ke karolo ea bohlokoa ea mokhoa ona. Pele ho phekolo, hlahala ea mokuli e hlahlojoa ho khetholla litšobotsi tsa eona tse khethehileng, tse kang liphetoho tsa lefutso le matšoao a ho itšireletsa mafung. Lintlha tsena li sebelisoa ho khetha li-agent tse sebetsang ka ho fetisisa tsa chemotherapeutic le immunotherapeutic bakeng sa hlahala eo. Mokhoa ona oa motho ka mong o eketsa menyetla ea katleho ea kalafo mme o fokotsa kotsi ea ho ba le maikutlo a mabe.

Karolo ea Tlhahlobo ea Biomarker

Tlhahlobo ea biomarker e bohlokoa bakeng sa chemoimmunotherapy ea motho ka mong. Ka ho khetholla li-biomarker tse itseng ka har'a hlahala, lingaka li ka bolela esale pele hore na ke lithethefatsi life tse ka sebetsang hantle. Mohlala, polelo ea PD-L1 e ka bonts'a karabelo e ka bang teng ho li-immunotherapies tse itseng.

Mokhoa: Mohato ka Mohato

The Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy hangata mokhoa ona o kenyelletsa mehato e latelang:

1. Tekolo ea pele ho ts'ebetso: Mokuli o hlahlojoa ka botlalo, ho kenyelletsa le lithuto tsa litšoantšo le tlhahlobo ea biomarker.
2. Moralo oa phekolo: Ho ipapisitsoe le tlhahlobo, ho etsoa moralo oa kalafo oa motho ka mong, o totobatsang li-chemotherapeutic le immunotherapeutic agents tse lokelang ho sebelisoa.
3. Mokhoa: Mokuli o kena ts'ebetsong e fokolang haholo, nakong eo meriana e kenngoa ka ho toba ka har'a hlahala tlas'a tataiso ea setšoantšo.
4. Tlhokomelo ka mor'a ts'ebetso: Mokuli o behiloe leihlo ka hloko bakeng sa litla-morao leha e le life kapa mathata. Liphuputso tse latelang tsa litšoantšo li etsoa ho hlahloba karabelo ea phekolo.

Melemo e ka khonehang ea Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy

Mokhoa ona o mocha o fana ka melemo e mengata ha e bapisoa le kalafo ea mofetše oa setso:

• Matla a ntlafetseng: Tšebeliso e phahameng ea lithethefatsi sebakeng sa hlahala.
• Chefo e fokotsehileng: Tšusumetso e tlase ea systemic ho chemotherapy.
• Kalafo e ikhethileng: E ipapisitse le litšobotsi tsa hlahala ea mokuli ka mong.
• E hlasela hanyane: Ho hlaphoheloa kapele le bohloko bo fokolang.
• Monyetla oa ho susumetsa 'mele oa ho itšireletsa mafung: Ho tsamaisoa ha intratumoral ea immunotherapeutic agents ho ka susumetsa sesole sa 'mele ho hlasela hlahala.

Mehlala ea Kankere e Tšoaroang ka Intratumoral Chemoimmunotherapy

Ha lipatlisiso li ntse li tsoela pele, Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy e bontšitse tšepo ea ho alafa mefuta e sa tšoaneng ea kankere, ho akarelletsa:

• Melanoma
• Hepatocellular carcinoma (Kankere ea sebete)
• Kankere ea Matsoele
• Kankere ea Lefu
• Lihlahala tse ling tse tiileng

Lintlha tsa Tlhahlobo ea Tleliniki le Lipatlisiso

Liteko tse ngata tsa kliniki li ntse li tsoela pele ho lekola polokeho le katleho ea Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy. Liphetho tsa pele lia ts'episa, 'me liphuputso tse ling li bonts'a ho fokotseha ho hoholo ha hlahala le litekanyetso tse ntlafetseng tsa ho pholoha ho bakuli ba phekoloang ka mokhoa ona. Ka mohlala, phuputso e phatlalalitsoeng ho Journal of Clinical Oncology e bontšitse ntlafatso e kholo ea ho phela ka kakaretso ho bakuli ba nang le melanoma e tsoetseng pele ba tšoaroang ka intratumoral immunotherapy ha ba bapisoa le ba phekoloang ka systemic chemotherapy. ^[1].

Bokamoso ba Intratumoral Chemoimmunotherapy

Tšimo ea intratumoral chemoimmunotherapy e ntse e tsoela pele ka potlako. Litaelo tsa nako e tlang li kenyelletsa:

• Nts'etsopele ea li-chemotherapeutic le li-immunotherapeutic tse ncha le tse sebetsang haholoanyane.
• Mekhoa e ntlafetseng ea ho iketsetsa phekolo e itšetlehileng ka litšobotsi tsa tumor.
• Motsoako oa kalafo ea intratumoral le liphekolo tse ling tsa mofetše, joalo ka kalafo ea radiation le kalafo e lebisitsoeng.
• Tšebeliso ea nanotechnology ho tsamaisa lithethefatsi ka nepo sebakeng sa hlahala.

Khetho ea Bakuli le Litlhahlobo

Ha se bakuli bohle ba tšoanelehang bakeng sa Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy. Lintlha tse lokelang ho nahanoa li kenyelletsa:

• Boholo ba hlahala le sebaka
• Bophelo bo botle ka kakaretso ba mokuli
• Liphekolo tsa mofets'e tse fetileng
• Ho ba teng ha li-biomarker tse khethehileng

Ho hlahlojoa ka botlalo ke sehlopha sa li-multidisciplinary tsa oncologists, lingaka tse buoang le litsebi tse ling ke tsa bohlokoa ho fumana hore na mokhoa ona oa phekolo o loketse mokuli ea itseng. Bakuli ba batlang lintlha tse ling ba amohelehile ho ikopanya le rona bakeng sa tlhahlobo ea pele.

Likotsi tse ka 'nang tsa E-ba teng le Litla-morao

Joalo ka ts'ebetso efe kapa efe ea bongaka, Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy e na le likotsi le litla-morao tse ka bang teng. Tsena li ka kenyelletsa:

• Bohloko le ho ruruha sebakeng sa ente
• Tšoaetso
• Ho tsoa mali
• Lintho tse hananang le lithethefatsi
• Litla-morao tsa systemic tsa chemotherapy

Ho bohlokoa ho buisana ka likotsi tsena le ngaka ea hau pele u fumana kalafo.

Litšenyehelo le phihlello

Litsenyehelo tsa Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy e ka fapana ho itšetlehile ka lithethefatsi tse khethehileng tse sebelisoang, ho rarahana ha mokhoa ona, le sebaka sa setsi sa phekolo. Ho bohlokoa ho buisana ka litšenyehelo le mofani oa tlhokomelo ea bophelo le k'hamphani ea inshorense. Ho fihlella le hona e ka ba lebaka, kaha kalafo ena ha e so fumanehe hohle litsing tsohle tsa mofetše.

Qetello

Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy e emela mokhoa o mocha o tšepisang oa kalafo ea mofetše. Ka ho kopanya opereishene e fokolang haholo le chemoimmunotherapy ea motho ka mong, e fana ka monyetla oa ho ntlafatsa ts'ebetso, ho fokotsa chefo, le ho ntlafatsa boleng ba bophelo ba mokuli. Le hoja lipatlisiso tse ling li hlokahala, mokhoa ona o mocha o na le tšepiso e kholo bakeng sa bokamoso ba tlhokomelo ea mofetše. Ho Setsi sa Lipatlisiso sa Kankere sa Shandong Baofa, re ntse re inehetse bakeng sa tsoelo-pele ea bopula-maliboho kalafong ea mofetše le ho fa bakuli tlhokomelo e molemo ka ho fetisisa e ka khonehang. Ikopanye le rona ho ithuta haholoanyane ka likhetho tsa rona tse felletseng tsa kalafo ea mofetše.

Litšupiso

[1] Ribas, A., et al. (2018). Intratumoral Immunotherapy. Journal of Clinical Oncology, 36(9), 919-927.